Inpefa (sotagliflozin) — Medica
Heart failure, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit
Initial criteria
- Patient is age ≥ 18 years
Reauthorization criteria
- Patient continues to meet initial criteria
Approval duration
1 year